Latigo raises $150M to get non-opioid pain drugs through key tests
The round, which included more than a dozen investment firms, should give the startup enough cash to get late-stage data for its lead candidate.
The round, which included more than a dozen investment firms, should give the startup enough cash to get late-stage data for its lead candidate.
